Subsequent experimental validation in miR-223-OE cells and an in silico prediction revealed the novel mRNA targets of miR-223: INPP5B, RHOB, SKIL, and SYNE1. Abnormal miR-223 levels may provide clues to the pathophysiology of schizophrenia. Here, SKIL is linked to schizophrenia.